Diet and Clinical Outcomes in a Heart Failure Population
Philip Joseph(Population Health Research Institute), A. Picech, Sergio Andrés Nemi, Fernando Laņas(Universidad de La Frontera), Justin A. Ezekowitz(University of Alberta), Alex Grinvalds(Population Health Research Institute), Tara McCready(Population Health Research Institute), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Eva Lonn(McMaster University), Salim Yusuf(Population Health Research Institute), Patricio López‐Jaramillo(Universidad De Santander), Miguel Hominal, Ignacio MacKinnon, Guillermo Cursack, Kamilu M. Karaye(Aminu Kano Teaching Hospital), Alejandro Meiriño, Giuseppe Paterlini, Natalia Cluigt, Nana Pogosova(National Medical Research Center of Cardiology), Ambuj Roy, Minh Cuong Duong, Khalid F. AlHabib(King Saud University), Ahmed ElSayed(Alzaiem Alazhari University), Servando Cardona, Philip Joseph, Juan Esteban Gómez‐Mesa(Inserm), Darryl P. Leong(Population Health Research Institute), M. Castoldi(Istituto Nazionale di Fisica Nucleare, Laboratori Acceleratori e Superconduttività Applicata), W Casali, Álvaro Avezum(Sociedade de Nefrologia do Estado de São Paulo), Mahshid Dehghan(Population Health Research Institute), Victoria Miller(Population Health Research Institute), Javier Hasbani, Aldo P. Maggioni(Health Care Foundation), Georg Ertl(Bielefeld University), Juan Manuel Domı́nguez, Carlos F. Garcia, Lars H. Lund(Karolinska University Hospital), Kumar Balasubramanian(Population Health Research Institute), M.L. Diaz(Estudios Clínicos Latinoamérica), F.A. Bilancieri, M.S. Copponi, M.S. Cursack, E. Hasbanl, Ruben Garcia Duran, Ahmet Temizhan(Sağlık Bilimleri Üniversitesi)
Cited by 1
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|The Lancet|2020|9.8k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k